Coronavirus update | Why is India pushing ahead with Hydroxychloroquine? | The Hindu In Focus Podcast

Updated - May 27, 2020 03:30 am IST

The Indian Council for Medical Research said on May 26 that no major side-effects of  Hydroxychloroquine  have been found in studies in India and its use should be continued in preventive treatment for COVID-19. This all comes in the backdrop of the World Health Organization (WHO) suspending the testing  of the drug in COVID-19 patients temporarily in its global study following safety concerns. Why is India pushing ahead with the drug and what are the kinds of trials it is running to test its efficacy?

Guests : Jacob Koshy , Deputy Science Editor, The Hindu .

Find the In Focus podcast on Spotify, Apple Podcasts and Stitcher. Search for In Focus by The Hindu.

Write to us with comments and feedback at socmed4@thehindu.co.in

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.